Clinical trials
Active, not recruiting Thyroid Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 11 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 60 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 8 |
| National Cancer Institute (NCI) | 7 |
| M.D. Anderson Cancer Center | 5 |
| Eli Lilly and Company | 4 |
| Exelixis | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| National Taiwan University Hospital | 2 |
| Pfizer | 2 |
| University Health Network, Toronto | 2 |
| Aarhus University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 60 |
| Melanoma | 12 |
| Thyroid Cancer, Papillary | 12 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Cholangiocarcinoma | 8 |
| Adenocarcinoma, Follicular | 7 |
| Carcinoma, Medullary | 7 |
| Breast Neoplasms | 6 |
| Colonic Neoplasms | 6 |
| Colorectal Neoplasms | 6 |
Trials
Showing 51 to 60 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.